Previous studies have indicated that in hormone receptors-positive (HR+) and human epidermal growth factor receptor 2-positive (HER-2+) ABC patients, the prognosis of dnMBC is better than that of rMBC (12–15). The gene discussed is ERBB2; the disease is aneurysmal bone cyst.